Guardian Pharmacy Services (GRDN) Cost of Revenue (2023 - 2026)

Guardian Pharmacy Services has disclosed Cost of Revenue across 4 years of filings, most recently posting $260.3 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $260.3 million, down 1.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 11.92% YoY), and the FY2025 annual result was $1.2 billion, up 17.47% from the prior year.
• Cost of Revenue came in at $260.3 million for Q1 2026 at Guardian Pharmacy Services, down from $312.1 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $312.1 million in Q4 2025 to a low of $210.5 million in Q3 2023.
• The 4-year median for Cost of Revenue is $260.3 million (2026), against an average of $257.9 million.
• Across the five-year window, Cost of Revenue advanced 20.41% in 2024 and declined 1.76% in 2026, its largest moves.
• Guardian Pharmacy Services' Cost of Revenue stood at $226.5 million in 2023, then gained by 19.86% to $271.5 million in 2024, then climbed by 14.97% to $312.1 million in 2025, then retreated by 16.61% to $260.3 million in 2026.
• The last three Cost of Revenue figures came in at $260.3 million (Q1 2026), $312.1 million (Q4 2025), and $302.7 million (Q3 2025), per Business Quant data.